1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
96.69%
Cash & equivalents growing 96.69% while AGEN's declined -23.11%. Peter Lynch would see this as a sign of superior liquidity management.
No Data
No Data available this quarter, please select a different quarter.
96.69%
Below half of AGEN's -23.11%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
119.86%
Other current assets growth < half of AGEN's -23.88%. David Dodd sees a leaner approach to short-term items.
94.31%
Below half of AGEN's -22.43%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-6.34%
Below half AGEN's 3.43%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.92%
Below half of AGEN's 1.44%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
78.33%
Below half of AGEN's -15.95%. Michael Burry sees a potential red flag for stagnation or capital shortage.
-11.61%
Less than half of AGEN's 49.62%. David Dodd sees a more disciplined AP approach or lower volume.
-42.55%
Less than half of AGEN's 1.20%. David Dodd sees much smaller short-term leverage burden vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
11.61%
1.25-1.5x AGEN's 8.44%. Bruce Berkowitz checks if there's a competitive advantage in forward billing.
No Data
No Data available this quarter, please select a different quarter.
-11.56%
Less than half of AGEN's 15.38%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.36%
Above 1.5x AGEN's -5.05%. Michael Burry sees a strong spike vs. competitor. Check coverage and debt ratios.
No Data
No Data available this quarter, please select a different quarter.
-11.23%
Less than half of AGEN's 0.85%. David Dodd sees far fewer liability expansions relative to competitor.
36.01%
Above 1.5x AGEN's 2.31%. Michael Burry suspects heavy new equity expansion or dilution.
-2.61%
0.5-0.75x AGEN's -4.37%. Martin Whitman is wary of weaker retention or lower profitability.
-6.95%
Less than half of AGEN's 51.42%. David Dodd sees fewer intangible or market-driven swings than competitor.
No Data
No Data available this quarter, please select a different quarter.
193.87%
Below half AGEN's -35.38%. Michael Burry sees potential underperformance in building shareholder capital.
78.33%
Below half AGEN's -15.95%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-9.95%
Less than half of AGEN's 6.47%. David Dodd sees less overall debt expansion vs. competitor.
-116.79%
Less than half of AGEN's 27.60%. David Dodd sees better deleveraging or stronger cash buildup than competitor.
